@Lower_Fox @NoUse4aName781 Well, for starters, Iโll post whatever I want on my social media. Secondly itโs merely a product review based on the packaging followed by my opinion. And in closing, this company will survive my post without you defending itโฆ.even if it does reach my millions of followers!
@NoUse4aName781 ๐๐๐ Iโm onboard with it just as much as you guys. Iโve been in for a long time and want it to succeed. Consumer critiques are needed for new products as itโs the only way to adjust issues.
@NoUse4aName781 Unfortunately mine wasnโtโฆ.I wish I did an unboxing video instead of the photosโฆ.also the old label was under the new one..I get itโฆit saves time and money. I think the packaging needs work but the product seems solid.
. @drgauravchandra concludes that #AI is key to timely diagnosis, the discovery of novel biomarkers and #Sepsis Early Warning Systems, and the development of novel immunomodulatory therapeutics. ๐ https://t.co/OaIJvinNju
#ENZC
@NonFungieLee โJulyโs going to be huge.โThen thereโs the human side to investing, the emotional side which frustrates a lot of people. That side isnโt the fault of the company at all. All said Iโm experiencing impatience which is leading to the negative outlook on the push back.
@NonFungieLee Hats off to Dr. C for his interaction and passion for this side of it. I also think it can hurt sometimes by providing early updates probably out of excitement. For example the timelines on specific milestones. Hashtags by an investor relations account donโt help either
@NonFungieLee I did and I remember being super excited when it came out. Thereโs a few parts to my thinking good and bad. The first being that itโs very rare common investors interact with any high ranking person in the company. Maybe not so much in this OTC but in general.
Knowledge is power, but it comes with responsibility. The value of #AI to healthcare lies in better collaboration, innovation, the inclusion of all stakeholders in decision making, & integrity in data custodianship. @drgauravchandra@BischofKirsten@YuanCommunity#OpenData2022
$ENZC Enzolytics, Inc. clinical products will come to the market within 6 months to a year and we expect a ๐ฅMONUMENTAL SHIFT๐ฅ #ENZC
https://t.co/G0drapDf5F